肿瘤新血管生成抑制剂的研究进展
Progess in tumor angiogenesis inhibitor
出处
《儿科药学杂志》
CAS
2003年第6期13-16,38,共5页
Journal of Pediatric Pharmacy
二级参考文献9
-
1Yamaoka M, Yamamoto T, Masaki T,et al.Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).Cancer Res, 1993,53:4262-4267.
-
2Bergers G, Javaherian K, Lo KM, et al.Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.Science,1999,284:808-812.
-
3Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.Breast Cancer Res Treat,1995,36:169-180.
-
4Zhang HT, Craft P, Scott PA, et al.Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.J Natl Cancer Inst,1995,87:213-219.
-
5Wang G, Dong Z, Xu G, et al. The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis.J Cancer Res Clin Oncol,1998,124:615-620.
-
6Kusaka M, Sudo K, Matsutani E, et al.Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).Br J Cancer,1994,69:212-216.
-
7Mori S, Ueda T, Kuratsu S, et al.Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma.Int J Cancer, 1995,61:148-152.
-
8Kudelka AP, Verschraegen CF, Loyer E. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470.N Engl J Med, 1998,338:991-992.
-
9马晓春,张玲,马红,于润江.肺癌血管内皮生长因子表达及其与血管新生和肿瘤细胞增殖关系的研究[J].中华内科杂志,2001,40(1):32-35. 被引量：18
共引文献3
-
1庄伟,李新丰.栓塞化疗治疗原发性肝癌的改良和发展[J].河北医学,2006,12(2):187-189.
-
2王晓杰,简伟杰,杨国伟,李越.BBD-效应面法优选七血酊剂制备工艺及其对小鼠胃肠黏膜刺激的作用[J].中华中医药杂志,2020,35(11):5721-5725. 被引量：1
-
3王小华,张平.血管生成抑制剂TNP-470抗肿瘤研究和应用进展[J].南华大学学报（医学版）,2004,32(2):233-235.
-
1傅文.质量保证体系是药检所的命脉[J].中国药事,1998,12(5):279-280. 被引量：2
-
2孙燕.肿瘤药物治疗的新进展[J].临床医学杂志,1989,5(3):119-121.
-
3范柏林,刘增路,唐玫,周黎敏,毛振民.血管生成抑制剂研究进展[J].中国现代应用药学,2009,26(1):22-25. 被引量：4
-
4陈子明,汪中文,黄洪波,陈玉婵,章卫民,张长生,鞠建华.海洋真菌Xylaria sp.SOF11中细胞松弛素类化合物的研究[J].天然产物研究与开发,2011,23(5):801-804.
-
5高晶,袁淑杰,姜媛媛,李郑武.贝伐单抗在抗肿瘤临床上的应用[J].科学中国人,2016(3X).
-
6王利国,潘超美,贺红,徐鸿华.抗肿瘤药用植物及其内生菌活性代谢产物研究进展[J].广州中医药大学学报,2008,25(2):183-186. 被引量：15
-
7张艳.医院药品质量管理工作的几点体会[J].工企医刊,2010,23(2):83-83. 被引量：1
-
8秦峥,郑尚季.抗肿瘤中药单体研究进展[J].中国药物评价,2014,31(2):89-91. 被引量：10
-
9方昱,张虹,李英.群体药动学在抗肿瘤药物及其代谢酶研究中的应用进展[J].中国医院药学杂志,2010,30(10):858-861. 被引量：3
-
10金伟款.新血管生成抑制剂kallistatin[J].国外药讯,2003(4):21-21.
